Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GX Genomics & Biotechnology ETF (NQ: GNOM )

11.10 -0.02 (-0.18%)
Official Closing Price Updated: 4:15 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,922
Open 11.05
Bid (Size) 10.60 (2)
Ask (Size) 11.75 (1)
Prev. Close 11.12
Today's Range 10.94 - 11.11
52wk Range 8.630 - 12.53
Shares Outstanding 33,418,720
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Gene Editing Stocks with Potential to Transform Medicine
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. 
Via InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace

Performance

YTD
-4.97%
-4.97%
1 Month
+0.27%
+0.27%
3 Month
+7.31%
+7.31%
6 Month
+1.64%
+1.64%
1 Year
+12.46%
+12.46%

More News

Read More
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Via InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
3 Stocks That Could Be the Next Big Thing in Gene Editing
Via InvestorPlace
ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?
Via Talk Markets
3 Gene Editing Stocks With Unprecedented Surge Potential
Via InvestorPlace
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
Via InvestorPlace
3 Gene Editing Stocks to Generate Super-Charged Gains
Via InvestorPlace
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Via InvestorPlace
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
Via InvestorPlace
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
Via InvestorPlace
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM
Via Talk Markets
A Comprehensive Guide To Genomic ETFs
Via Talk Markets
Top-Performing Biotech ETFs of Last Week
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.